14-MYEL-06-AB (Array-520-215): A Multicenter Phase II Study of Single-agent Filanesib(ARRY-520-215) in Patients with Advanced Multiple Myeloma

Grants and Contracts Details

StatusFinished
Effective start/end date11/6/14 → 4/13/18

Funding

  • ICON Clinical Research: $74,913.00